Lista de obras -

A cautionary note on the immunohistochemical detection of BRAF v600e mutations in serrated lesions of the colon.

artículo científico publicado en 2015

A new member of the NY-ESO-1 gene family is ubiquitously expressed in somatic tissues and evolutionarily conserved

scientific article published on 01 September 2002

Antigen-specific immunity in neuroblastoma patients: antibody and T-cell recognition of NY-ESO-1 tumor antigen.

artículo científico publicado en 2003

Assessing colorectal cancer mismatch repair status in the modern era: a survey of current practices and re-evaluation of the role of microsatellite instability testing

artículo científico publicado en 2018

Assessment of CD4+ T cells specific for the tumor antigen SSX-1 in cancer-free individuals.

artículo científico publicado en 2006

Autoantibodies against cancer antigens

artículo científico publicado en 2009

Bcl-xL promotes metastasis independent of its anti-apoptotic activity

artículo científico publicado en 2016

CD4+ T cell responses to SSX-4 in melanoma patients

artículo científico publicado en 2005

CD8(+) T cell responses against a dominant cryptic HLA-A2 epitope after NY-ESO-1 peptide immunization of cancer patients

artículo científico publicado en 2002

CT-X antigen expression in human breast cancer.

artículo científico publicado en 2009

CT7 (MAGE-C1) antigen expression in normal and neoplastic tissues

artículo científico publicado en 2002

CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens

artículo científico publicado en 2008

Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets.

artículo científico publicado en 2002

Cancer-testis antigen expression in digestive tract carcinomas: frequent expression in esophageal squamous cell carcinoma and its precursor lesions

artículo científico publicado en 2013

Cancer/testis (CT) antigens: potential targets for immunotherapy

artículo científico publicado en 2009

Cancer/testis antigen CT45: analysis of mRNA and protein expression in human cancer

artículo científico publicado en 2009

Cancer/testis antigen expression and autologous humoral immunity to NY-ESO-1 in gastric cancer

scientific article published on 01 November 2004

Cancer/testis antigens: an expanding family of targets for cancer immunotherapy

artículo científico publicado en 2002

Characterization of human colon cancer antigens recognized by autologous antibodies

Chromosome X-encoded Cancer/Testis antigens are less frequently expressed in non-seminomatous germ cell tumors than in seminomas ⬇️

artículo científico publicado el 10 de mayo de 2013

Chromosome X-encoded cancer/testis antigens show distinctive expression patterns in developing gonads and in testicular seminoma

artículo científico publicado el 20 de octubre de 2011

Clinical, pathologic, and molecular features of early-onset colorectal carcinoma

scientific article published on 01 April 2009

Colon cancer associated transcript-1: a novel RNA expressed in malignant and pre-malignant human tissues.

artículo científico publicado en 2011

Cross-presentation of HLA class I epitopes from exogenous NY-ESO-1 polypeptides by nonprofessional APCs

artículo científico publicado en 2003

Diagnostic usefulness of HBME1, galectin-3, CK19, and CITED1 and evaluation of their expression in encapsulated lesions with questionable features of papillary thyroid carcinoma

artículo científico publicado en 2006

Distinct but overlapping T helper epitopes in the 37-58 region of SSX-2

artículo científico publicado en 2005

Distinct expression patterns of the immunogenic differentiation antigen NY-BR-1 in normal breast, testis and their malignant counterparts

artículo científico publicado en 2008

ECSA/DPPA2 is an embryo-cancer antigen that is coexpressed with cancer-testis antigens in non-small cell lung cancer

scientific article published on 01 June 2008

Effects of CT-Xp Gene Knock down in Melanoma Cell Lines ⬇️

artículo científico publicado el 1 de abril de 2013

Expression and immunogenicity of NY-ESO-1 in hepatocellular carcinoma.

artículo científico publicado en 2006

Expression of cancer testis antigen CT45 in classical Hodgkin lymphoma and other B-cell lymphomas

artículo científico publicado en 2010

Expression of cancer-testis genes in human hepatocellular carcinomas

artículo científico publicado el 19 de septiembre de 2002

Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease.

artículo científico publicado en 2003

Expression of cancer/testis (CT) antigens in lung cancer

artículo científico publicado en 2003

Expression of multiple cancer/testis (CT) antigens in breast cancer and melanoma: Basis for polyvalent CT vaccine strategies

artículo científico publicado en 1998

Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer

artículo científico publicado en 2003

Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters

artículo científico publicado en 2005

Gene expression profiling separates chromophobe renal cell carcinoma from oncocytoma and identifies vesicular transport and cell junction proteins as differentially expressed genes.

artículo científico publicado en 2006

Gene fusions between TMPRSS2 and ETS family genes in prostate cancer: frequency and transcript variant analysis by RT-PCR and FISH on paraffin-embedded tissues

artículo científico publicado en 2007

Genome-wide analysis of cancer/testis gene expression

artículo científico publicado en 2008

HLA-DP4 expression and immunity to NY-ESO-1: correlation and characterization of cytotoxic CD4+ CD25- CD8- T cell clones.

artículo científico publicado en 2004

Humoral and cellular immune responses against the breast cancer antigen NY-BR-1: definition of two HLA-A2 restricted peptide epitopes

artículo científico publicado en 2005

IFN-gamma enables cross-presentation of exogenous protein antigen in human Langerhans cells by potentiating maturation

scholarly article

Identification and characterization of mouse SSX genes: a multigene family on the X chromosome with restricted cancer/testis expression☆ ⬇️

artículo científico publicado el 1 de diciembre de 2003

Identification of CT46/HORMAD1, an immunogenic cancer/testis antigen encoding a putative meiosis-related protein.

artículo científico publicado en 2005

Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51.

artículo científico publicado en 2002

Identification of a new cancer/testis gene family, CT47, among expressed multicopy genes on the human X chromosome.

artículo científico publicado en 2006

Identification of an SSX-2 epitope presented by dendritic cells to circulating autologous CD4+ T cells.

artículo científico publicado en 2004

Identification of cancer/testis genes by database mining and mRNA expression analysis

artículo científico publicado en 2002

Identification of cancer/testis-antigen genes by massively parallel signature sequencing

artículo científico publicado en 2005

Identification of the gonad-specific anion transporter SLCO6A1 as a cancer/testis (CT) antigen expressed in human lung cancer.

artículo científico publicado en 2004

Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum.

artículo científico publicado en 2002

Immunohistochemical analysis of RHAMM expression in normal and neoplastic human tissues: a cell cycle protein with distinctive expression in mitotic cells and testicular germ cells.

artículo científico publicado en 2018

Immunohistochemical and molecular analysis of human melanomas for expression of the human cancer-testis antigens NY-ESO-1 and LAGE-1.

artículo científico publicado en 2004

Immunohistochemical and molecular features of sporadic and FAP-associated duodenal adenomas of the ampullary and nonampullary mucosa.

artículo científico publicado en 2008

Immunomic analysis of human sarcoma

artículo científico publicado en 2003

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

artículo científico publicado en 2005

Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patients

artículo científico publicado en 2006

Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma

artículo científico publicado en 2005

MicroRNA Expression Aids the Preoperative Diagnosis of Pancreatic Ductal Adenocarcinoma ⬇️

artículo científico publicado el 1 de julio de 2012

MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma

artículo científico publicado en 2008

Multiple Cancer/Testis Antigens Are Preferentially Expressed in Hormone-Receptor Negative and High-Grade Breast Cancers ⬇️

artículo científico publicado el 18 de marzo de 2011

NY-BR-1 is a differentiation antigen of the mammary gland

artículo científico publicado en 2007

NY-BR-1 protein expression in breast carcinoma: a mammary gland differentiation antigen as target for cancer immunotherapy

artículo científico publicado en 2007

NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.

artículo científico publicado en 2003

NY-ESO-1 expression and immunogenicity in esophageal cancer.

artículo científico publicado en 2004

NY-ESO-1 expression and immunogenicity in malignant and benign breast tumors

artículo científico publicado en 2004

NY-ESO-1 mRNA expression and immunogenicity in advanced prostate cancer.

artículo científico publicado en 2003

NY-ESO-1 protein expression in primary breast carcinoma and metastases: correlation with CD8+ T-cell and CD79a+ plasmacytic/B-cell infiltration

artículo científico publicado en 2007

NY-ESO-1: review of an immunogenic tumor antigen

artículo científico publicado en 2006

PLAC1, a trophoblast-specific cell surface protein, is expressed in a range of human tumors and elicits spontaneous antibody responses

artículo científico publicado en 2007

Physical interaction of two cancer-testis antigens, MAGE-C1 (CT7) and NY-ESO-1 (CT6)

artículo científico publicado en 2006

Preferential nuclear and cytoplasmic NY-BR-1 protein expression in primary breast cancer and lymph node metastases

scientific article published on 01 May 2006

Quantitative real-time RT-PCR analysis of NY-ESO-1 and LAGE-1a mRNA expression in normal tissues and tumors, and correlation of the protein expression with the mRNA copy number

artículo científico publicado en 2005

Real-Time, label-free monitoring of tumor antigen and serum antibody interactions

scientific article published on 01 November 2004

Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans

artículo científico publicado en 2004

SSX antigens as tumor vaccine targets in human sarcoma

artículo científico publicado en 2003

Serological analysis of expression cDNA libraries (SEREX): an immunoscreening technique for identifying immunogenic tumor antigens

artículo científico publicado en 2005

Seromic profiling of ovarian and pancreatic cancer

artículo científico publicado en 2010

Serrated polyps with "intermediate features" of sessile serrated polyp and microvesicular hyperplastic polyp: a practical approach to the classification of nondysplastic serrated polyps

scientific article published on 01 March 2008

Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses

artículo científico publicado en 2003

Survivin as a useful adjunct marker for the grading of papillary urothelial carcinoma.

artículo científico publicado en 2008

The SSX gene family: characterization of 9 complete genes

artículo científico publicado en 2002

The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation

artículo científico publicado en 2005

The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer.

artículo científico publicado en 2013

Urine antibody against human cancer antigen NY-ESO-1

artículo científico publicado en 2002

Vaccine-induced CD4+ T cell responses to MAGE-3 protein in lung cancer patients

artículo científico publicado en 2004

Lista de obras de

A cautionary note on the immunohistochemical detection of BRAF v600e mutations in serrated lesions of the colon.

A new member of the NY-ESO-1 gene family is ubiquitously expressed in somatic tissues and evolutionarily conserved

Antigen-specific immunity in neuroblastoma patients: antibody and T-cell recognition of NY-ESO-1 tumor antigen.

Assessing colorectal cancer mismatch repair status in the modern era: a survey of current practices and re-evaluation of the role of microsatellite instability testing

Assessment of CD4+ T cells specific for the tumor antigen SSX-1 in cancer-free individuals.

Autoantibodies against cancer antigens

Bcl-xL promotes metastasis independent of its anti-apoptotic activity

CD4+ T cell responses to SSX-4 in melanoma patients

CD8(+) T cell responses against a dominant cryptic HLA-A2 epitope after NY-ESO-1 peptide immunization of cancer patients

CT-X antigen expression in human breast cancer.

CT7 (MAGE-C1) antigen expression in normal and neoplastic tissues

CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens

Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets.

Cancer-testis antigen expression in digestive tract carcinomas: frequent expression in esophageal squamous cell carcinoma and its precursor lesions

Cancer/testis (CT) antigens: potential targets for immunotherapy

Cancer/testis antigen CT45: analysis of mRNA and protein expression in human cancer

Cancer/testis antigen expression and autologous humoral immunity to NY-ESO-1 in gastric cancer

Cancer/testis antigens: an expanding family of targets for cancer immunotherapy

Characterization of human colon cancer antigens recognized by autologous antibodies

Chromosome X-encoded Cancer/Testis antigens are less frequently expressed in non-seminomatous germ cell tumors than in seminomas ⬇️

Chromosome X-encoded cancer/testis antigens show distinctive expression patterns in developing gonads and in testicular seminoma

Clinical, pathologic, and molecular features of early-onset colorectal carcinoma

Colon cancer associated transcript-1: a novel RNA expressed in malignant and pre-malignant human tissues.

Cross-presentation of HLA class I epitopes from exogenous NY-ESO-1 polypeptides by nonprofessional APCs

Diagnostic usefulness of HBME1, galectin-3, CK19, and CITED1 and evaluation of their expression in encapsulated lesions with questionable features of papillary thyroid carcinoma

Distinct but overlapping T helper epitopes in the 37-58 region of SSX-2

Distinct expression patterns of the immunogenic differentiation antigen NY-BR-1 in normal breast, testis and their malignant counterparts

ECSA/DPPA2 is an embryo-cancer antigen that is coexpressed with cancer-testis antigens in non-small cell lung cancer

Effects of CT-Xp Gene Knock down in Melanoma Cell Lines ⬇️

Expression and immunogenicity of NY-ESO-1 in hepatocellular carcinoma.

Expression of cancer testis antigen CT45 in classical Hodgkin lymphoma and other B-cell lymphomas

Expression of cancer-testis genes in human hepatocellular carcinomas

Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease.

Expression of cancer/testis (CT) antigens in lung cancer

Expression of multiple cancer/testis (CT) antigens in breast cancer and melanoma: Basis for polyvalent CT vaccine strategies

Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer

Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters

Gene expression profiling separates chromophobe renal cell carcinoma from oncocytoma and identifies vesicular transport and cell junction proteins as differentially expressed genes.

Gene fusions between TMPRSS2 and ETS family genes in prostate cancer: frequency and transcript variant analysis by RT-PCR and FISH on paraffin-embedded tissues

Genome-wide analysis of cancer/testis gene expression

HLA-DP4 expression and immunity to NY-ESO-1: correlation and characterization of cytotoxic CD4+ CD25- CD8- T cell clones.

Humoral and cellular immune responses against the breast cancer antigen NY-BR-1: definition of two HLA-A2 restricted peptide epitopes

IFN-gamma enables cross-presentation of exogenous protein antigen in human Langerhans cells by potentiating maturation

Identification and characterization of mouse SSX genes: a multigene family on the X chromosome with restricted cancer/testis expression☆ ⬇️

Identification of CT46/HORMAD1, an immunogenic cancer/testis antigen encoding a putative meiosis-related protein.

Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51.

Identification of a new cancer/testis gene family, CT47, among expressed multicopy genes on the human X chromosome.

Identification of an SSX-2 epitope presented by dendritic cells to circulating autologous CD4+ T cells.

Identification of cancer/testis genes by database mining and mRNA expression analysis

Identification of cancer/testis-antigen genes by massively parallel signature sequencing

Identification of the gonad-specific anion transporter SLCO6A1 as a cancer/testis (CT) antigen expressed in human lung cancer.

Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum.

Immunohistochemical analysis of RHAMM expression in normal and neoplastic human tissues: a cell cycle protein with distinctive expression in mitotic cells and testicular germ cells.

Immunohistochemical and molecular analysis of human melanomas for expression of the human cancer-testis antigens NY-ESO-1 and LAGE-1.

Immunohistochemical and molecular features of sporadic and FAP-associated duodenal adenomas of the ampullary and nonampullary mucosa.

Immunomic analysis of human sarcoma

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patients

Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma

MicroRNA Expression Aids the Preoperative Diagnosis of Pancreatic Ductal Adenocarcinoma ⬇️

MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma

Multiple Cancer/Testis Antigens Are Preferentially Expressed in Hormone-Receptor Negative and High-Grade Breast Cancers ⬇️

NY-BR-1 is a differentiation antigen of the mammary gland

NY-BR-1 protein expression in breast carcinoma: a mammary gland differentiation antigen as target for cancer immunotherapy

NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.

NY-ESO-1 expression and immunogenicity in esophageal cancer.

NY-ESO-1 expression and immunogenicity in malignant and benign breast tumors

NY-ESO-1 mRNA expression and immunogenicity in advanced prostate cancer.

NY-ESO-1 protein expression in primary breast carcinoma and metastases: correlation with CD8+ T-cell and CD79a+ plasmacytic/B-cell infiltration

NY-ESO-1: review of an immunogenic tumor antigen

PLAC1, a trophoblast-specific cell surface protein, is expressed in a range of human tumors and elicits spontaneous antibody responses

Physical interaction of two cancer-testis antigens, MAGE-C1 (CT7) and NY-ESO-1 (CT6)

Preferential nuclear and cytoplasmic NY-BR-1 protein expression in primary breast cancer and lymph node metastases

Quantitative real-time RT-PCR analysis of NY-ESO-1 and LAGE-1a mRNA expression in normal tissues and tumors, and correlation of the protein expression with the mRNA copy number

Real-Time, label-free monitoring of tumor antigen and serum antibody interactions

Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans

SSX antigens as tumor vaccine targets in human sarcoma

Serological analysis of expression cDNA libraries (SEREX): an immunoscreening technique for identifying immunogenic tumor antigens

Seromic profiling of ovarian and pancreatic cancer